Nanotherapeutics for Nose-to-Brain Drug Delivery: An Approach to Bypass the Blood Brain Barrier

Treatment of neurodegenerative diseases or other central nervous system (CNS) disorders has always been a significant challenge. The nature of the blood-brain barrier (BBB) limits the penetration of therapeutic molecules to the brain after oral or parenteral administration, which, in combination wit...

Descripción completa

Detalles Bibliográficos
Autores principales: Lee, David, Minko, Tamara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704573/
https://www.ncbi.nlm.nih.gov/pubmed/34959331
http://dx.doi.org/10.3390/pharmaceutics13122049

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8704573/
https://www.ncbi.nlm.nih.gov/pubmed/34959331
http://dx.doi.org/10.3390/pharmaceutics13122049

Ejemplares similares